drugset / Trial / NCT00777413

Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions

NCT00777413

Completed 24 enrolled Ranbaxy Laboratories Limited
RandomizedCrossoverOpen-label

Summary

The purpose of this study was to determine the bioequivalence of Minocycline formulations after administration of single doses to normal healthy subjects under fed conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.

Timeline

Start
2002-11
Primary completion
2002-11
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg

Indications

No indication recorded.